Page 71 - MNU-PM502- Pharmaeutical Microbiology Theoritical Book
P. 71

Pharm D- Clinical Pharmacy Program        Third Level          Pharmaceutical Microbiology& Antimicrobials (PM 502)


                  Monitoring pharmaceutical ingredients, and packaging components















                  Water

                  - Water systems should be monitored at points of use, storage tanks.


                  - Sterile products are manufactured using water for injection (WFI) as ingredient
                  water

                      -  The USP-recommended specifications are

                      -   as purified <100 CFU/mL

                  - Highly purified and WFI 10 CFU/100mL





                  Container Integrity Testing

              •  Integrity of container/closure system is initially validated by

              •  Filling container with sterile growth medium
              •  Then inserting container in broth containing
                 10 CFU/ml of suitable microorganism





                  Media Fills Test (Process simulation)

              •  the performance of an aseptic manufacturing procedure using a sterile
                 microbiological growth medium in place of the drug solution.
              •  to test whether the aseptic procedures are adequate to prevent contamination

                 during actual drug production.
              •  A media fill is one part of the validation of an aseptic manufacturing process


                                                               58
   66   67   68   69   70   71   72   73   74   75   76